Literature DB >> 1367371

Cephamycin C biosynthesis in Streptomyces cattleya: nitrogen source regulation.

S Khaoua1, A Lebrihi, P Germain, G Lefebvre.   

Abstract

The production of cephamycin C by Streptomyces cattleya varies with the use of asparagine, glutamine or ammonium as nitrogen sources. Hydroxylase and expandase activities were demonstrated for the first time with this species. A study of the biosynthetic regulation of these enzymes by two different nitrogen sources, glutamine and asparagine, was carried out. Asparagine proved to be a better nitrogen source, both for enzymatic biosynthesis and production of cephamycin C. Moreover, an excess of asparagine in the culture environment provokes, simultaneously, a reduction in cephamycin C production and a decrease in the biosynthesis of expandase and hydroxylase.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367371     DOI: 10.1007/bf00184697

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  13 in total

1.  Biosynthesis of the beta-lactam antibiotic, thienamycin, by Streptomyces cattleya.

Authors:  J M Williamson; E Inamine; K E Wilson; A W Douglas; J M Liesch; G Albers-Schönberg
Journal:  J Biol Chem       Date:  1985-04-25       Impact factor: 5.157

2.  Analysis of penicillin N ring expansion activity from Streptomyces clavuligerus by ion-pair high-pressure liquid chromatography.

Authors:  S E Jensen; D W Westlake; S Wolfe
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

3.  Deacetoxycephalosporin C synthetase and deacetoxycephalosporin C hydroxylase are two separate enzymes in Streptomyces clavuligerus.

Authors:  S E Jensen; D W Westlake; S Wolfe
Journal:  J Antibiot (Tokyo)       Date:  1985-02       Impact factor: 2.649

4.  Carbon catabolite regulation of cephalosporin production in Streptomyces clavuligerus.

Authors:  Y Aharonowitz; A L Demain
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

5.  Thienamycin, a new beta-lactam antibiotic. I. Discovery, taxonomy, isolation and physical properties.

Authors:  J S Kahan; F M Kahan; R Goegelman; S A Currie; M Jackson; E O Stapley; T W Miller; A K Miller; D Hendlin; S Mochales; S Hernandez; H B Woodruff; J Birnbaum
Journal:  J Antibiot (Tokyo)       Date:  1979-01       Impact factor: 2.649

6.  The influence of 2-oxoglutarate on the activity of prolyl 4-hydroxylase.

Authors:  J J Nietfeld; L de Jong; A Kemp
Journal:  Biochim Biophys Acta       Date:  1982-06-04

7.  The application of materials balancing to the characterization of sequential secondary metabolite formation in Streptomyces cattleya NRRL 8057.

Authors:  M E Bushell; A Fryday
Journal:  J Gen Microbiol       Date:  1983-06

8.  Nitrogen nutrition and regulation of cephalosporin production in Streptomyces clavuligerus.

Authors:  Y Aharonowitz; A L Demain
Journal:  Can J Microbiol       Date:  1979-01       Impact factor: 2.419

9.  Repression and inhibition of cephalosporin synthetases in Streptomyces clavuligerus by inorganic phosphate.

Authors:  C Lübbe; S Wolfe; A L Demain
Journal:  Arch Microbiol       Date:  1985-01       Impact factor: 2.552

10.  Cephalosporin formation by cell-free extracts from Streptomyces clavuligerus.

Authors:  S E Jensen; D W Westlake; R J Bowers; S Wolfe
Journal:  J Antibiot (Tokyo)       Date:  1982-10       Impact factor: 2.649

View more
  2 in total

1.  Homologous expression of aspartokinase (ask) gene in Streptomyces clavuligerus and its hom-deleted mutant: effects on cephamycin C production.

Authors:  Gülay Özcengiz; Sezer Okay; Eser Ünsaldı; Bilgin Taşkın; Paloma Liras; Jacqueline Piret
Journal:  Bioeng Bugs       Date:  2010-01-11

Review 2.  Directed evolution and rational approaches to improving Streptomyces clavuligerus deacetoxycephalosporin C synthase for cephalosporin production.

Authors:  Kian-Sim Goo; Chun-Song Chua; Tiow-Suan Sim
Journal:  J Ind Microbiol Biotechnol       Date:  2009-03-07       Impact factor: 3.346

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.